A study from New York University Langone Medical Center, published in JAMA Psychiatry in January 2021, revealed that people living with schizophrenia who contracted Covid-19 were 2.7 times more likely to die than those without psychiatric illness — a risk surpassed only by age itself. Drawing on nearly 7,400 cases across New York's first pandemic wave, researchers found no direct biological mechanism to explain the disparity, pointing instead toward something older and more troubling: a healthcare system that has long failed its most vulnerable. The virus did not single out schizophrenia — it
ThePrint
· Jan 30, 2021
· health
· 3 min de leitura
High
Apuração: Verificado
Schizophrenia linked to 2.7x higher Covid mortality risk, second only to age
Schizophrenia patients with Covid-19 faced significantly elevated mortality risk, with 75 affected individuals among 7,348 positive cases studied in New York.
◉
Health & Medicine
8464 artigos relacionados
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% correspondência
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% correspondência
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% correspondência
Cobertura Relacionada
The Guardian · Aug 26
ADHD and autism complaints triple as NHS waits stretch to years
Complaints about autism and ADHD services in England tripled in five years as NHS waits exceed a year for most patients,…
News-Medical · Aug 26 Sewage monitoring detects pertussis outbreaks 10 weeks earlier than clinical reportsWastewater surveillance in Osaka detected pertussis DNA 4-16 weeks before clinical case reports, offering a proactive ea…
The Hindu · Aug 26 India's H1N1 surge is seasonal, not a new strain, ICMR assuresIndia experiences seasonal H1N1 rise with 1,777 cases in Delhi and 4,212 in Karnataka; ICMR confirms it's the familiar p…
Medical Xpress · Aug 26 Stress gene hyperactivity linked to schizophrenia in University of Sydney studyUniversity of Sydney researchers discovered that a stress-regulating gene (FKBP5) remains abnormally active in schizophr…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Medical research finding on psychiatric comorbidity and COVID mortality has no direct geopolitical implications; this is a public health/epidemiological study.
Escalation Risk
low
Confidence
HIGH
Lente Econômica
📈
Schizophrenia identified as second-highest Covid-19 mortality risk factor after age (2.7x higher death risk), with significant implications for healthcare resource allocation and mental health service capacity.
Market Signal
mixed
Confidence
HIGH
Healthcare and Hospitals
Mental Health Services
Pharmaceutical and Biotech
Insurance and Health Coverage
Long-term Care Facilities
Individuals with schizophrenia face substantially elevated healthcare costs, insurance premiums, and need for specialized Covid-19 treatment protocols. Households with affected members may experience increased out-of-pocket expenses and reduced workforce participation due to health complications.
Governments likely to prioritize schizophrenia patients in vaccination campaigns and Covid-19 treatment access; mental health services funding may increase; healthcare systems may require enhanced psychiatric-medical integration; insurance regulations may need adjustment for pre-existing psychiatric conditions; workplace accommodations and disability support programs may expand.